Blue Horseshoe Stocks

Blue Horseshoe Stocks: New Play, Updates & Extended Watchlist

Solar Wind Energy Tower, Inc. SWET

We’ve got a new item of interest in the penny arena to start things off this morning. Following a major run back in April, SWET has consolidated, and has been generally trading sideways ever since. We like the look of the chart, and feel that conditions are coming to a point where things could get interesting.

As you can see on the chart below, the RSI has held in there above the 50-line, there’s been a recent Golden Cross of the 50DMA over the 200DMA, and the MACD appears ready to start turning to the bullish side. It may not be too long before we see a pop out of this thing, so we’ll keep an eye peeled for that.

We also got word this morning that the company will be presenting at a prestigious investment banking conference at the beginning of next week:

ANNAPOLIS, MD, Jun 13, 2014 (Marketwired via COMTEX) — Solar Wind Energy Tower, Inc. (OTCQB: SWET) (the “Company”), the inventor of large Solar Wind Downdraft Tower structures capable of producing abundant, inexpensive electricity, announced that management will present at the National Investment Banking Association (NIBA) Conference to be held on June 16-18, 2014 at the Roosevelt Hotel in New York, NY.The NIBA Conference will give Solar Wind Energy Tower, Inc. access to a large audience at one time. NIBA’s membership is vast and multinational, and representing over 8,800 registered reps with an estimated $78B in assets under management. >>> FULL PR

Global Gaming Network, Inc. GBGM

With the vast array of stocks that we’re tracking all the time, it isn’t too much of a surprise when one of them perks up its head and regenerates our interest. Such was the case with GBGM yesterday; the last time we made mention of this stock in our daily reports was back on May 1st. At the time, we were monitoring the play for a bottom, which took the better part of the next month to reach.

GBGM touched down and found support at .0008 recently, and yesterday the sleeping giant was finally awakened as the company announced that it had retired 50 million shares of common stock, thereby reducing the number of outstanding shares 6%. What resulted was a significant upswing that took the stock as high as .0021 and generated gains of up to 162% for anyone that caught the bottom.

Options Ideas

OpenTable, Inc. OPEN

OPEN is gapping up tremendously this morning on news that the company is to be acquired by The Priceline Group. In situations like these, we like to monitor these high-flyers for subsequent dip-and-rip scenarios. Specifically regarding the options chain, when a strong move like this is properly utilized, it can spell big gains for those playing the Call side.

When something of this magnitude occurs, it can also create a sector-wide ripple effect, so we may also want to track stocks like LIVE, YELP, GRUB, and of course, PCLN.

Extended Watchlist:
GRPN, ICLD, LOCM, CNAT

Blue Horseshoe Stocks: CNAT, Options Ideas & Extended Watchlist

Conatus Pharmaceuticals, Inc. CNAT

CNAT is a stock that we first discovered as an FDA play back in early December, when one of the company’s treatments had been granted orphan drug status. At the time, the stock was trading at less than $5 a share, and by January, we saw a huge run that took it over $14.

It brought a few other swings in the following months, but had fallen to the back burner for quite some time as it consolidated. Yesterday it set off our alarms once again, springing back to life and running hard on heavy volume, so once again CNAT has our full attention.

After reaching as high as 9.90 during yesterday’s session, we’ll be on the lookout for possible dip-and-rip opportunities. We’d like to see support hold in the 8-8.50 range moving forward and if it can do that, chances to score quick strike gains on the bounce could be present.

Petroleo Brasiliero S.A. (Petrobras) PBR – Options

The PBR options chain has been a veritable cash cow for us this year as many of you already know, and we’ll continue to talk about it for as long as it continues to work in our favor. Yesterday was no letdown, as

All of the Call contracts that we’ve been monitoring ($14-15 Weekly Calls and the 07/19 $15 Calls) have been rocking, providing us with several shots at alarmingly high returns.

If PBR breaks over this morning’s pre-market high of 15.90, we may look to roll our strike price up to $16 (Possibly the 07/03 $16’s which closed @ .36 yesterday) and with how far the latest trend has taken us, we wouldn’t be too surprised to see that happen.

Extra Options Idea: Molson Coors Brewing Co. TAP

The TAP October $75 Calls showed an abnormal amount of trading activity yesterday, causing us to raise an eyebrow. Just for good measure, we’re going to throw those contracts up on our radar and monitor the situation.

Extended Watchlist:
KNDI, GERN, ZLCS, REPH, IDN, SNSS, SIGM, ARNA

Blue Horseshoe Stocks: ACHN, PBR & Extended Watchlist

Petroleo Brasiliero S.A. (Petrobras) PBR

PBR had another solid day yesterday, dipping below $15 only briefly where it found support at 14.88 before going on to push its upper limits over the course of the session, acvhieving a new high for us at 15.34.

All of the options contracts that we’ve been monitoring on PBR served up chances to gain a significant amount as the stock continued to bull its way north.

Even our longer-term idea, the 07/19 $15 Calls we’ve been tracking since last week from a low of .25 has already given us the triple-bagger we suggested it might in last Wednesday’s report. They closed out the day at .88, an overall move of 252% and it would appear they want to gap up along with PBR stock this morning, so we expect that figure to increase even further.

PBR has come a long way since we caught it coming off of 10-year lows back on March 21st. The stock itself has regained a lot of ground, coming from our observed low of 11.25 all the way up to current levels above $15. As we stated yesterday, if PBR has a tough time breaking through resistance at its previous swing high of 15.85, we’ll start to think about taking profits off of the table.

Achillion Pharmaceuticals, Inc. ACHN

We have to begin this morning by congratulating any of our readers who picked up on our coverage of ACHN yesterday, which allowed us the chance to make sizable gains for the second day in a row.

The stock gapped up as it did on Monday and continued to roll, trading in a range from 6.02 to 7.81 on the day, giving traders the opportunity to pocket close to 30% in profits intraday on inordinately high volume (To the tune of more than 22x the 3-month average).

From the low of 3.72 that we observed on Monday, the stock has already made a fantastic 110% move to the upside over the span of just two sessions.

The company put more news out this morning as well:

NEW HAVEN, Jun 11, 2014 (GLOBE NEWSWIRE via COMTEX) — Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that members of the senior management team will present a corporate overview at two upcoming investor conferences:– 2014 Wells Fargo Healthcare Conference on Wednesday, June 18, 2014 at 1:15 p.m. ET at the InterContinental Hotel in Boston, MA; and– JMP Health Care Conference 2014 on Tuesday, June 24, 2014 at 11:00 a.m. ET at the Westin New York Grand Central Hotel in New York, NY.

The live audio and subsequent archived webcasts of the Company’s presentations will be accessible from the Company’s investor relations website, http://ir.achillion.com.

Extended Watchlist:
NWBO, NAVB, BIOF, PEIX, END, XXII

Blue Horseshoe Stocks: PBR, ACHN, TMSH & More

Petroleo Brasiliero S.A. (Petrobras) PBR

We’ll kick things off this morning with PBR once again, as the stock had another banner day and behaved very much like we suggested it might. Yesterday we mentioned that the PBR chart was looking ripe for further northward movement and that’s just what we got.

The stock itself broke back over $15, which led to some prime opportunities in each and every set of options contracts that we outlined in our morning report. We said we’d be looking at Weekly Calls from $14-$15 for quick-flip intraday opportunities, and they all offered up some serious gains.

The $14 Calls traded from .74 to as high as 1.09, a chance for traders to score up to 47% in profits. The $14.50’s made a nice move up from .34 to .75, good for a nice double-bagger and more at +120% The $15’s fared extremely well also, running a whopping 290% from .11 up to .43.

Even our contracts of longer-term interest, the 07/19 $15 Calls (which we caught at a low of .25) made a solid intraday move from .54-.84, a highly respectable 55% increase.

All in all, for options traders, PBR was a paradise on Monday, and we’ll be continuously monitoring the situation as the week progresses. Major areas of resistance appear on the chart at 15.50 and 15.85, so failure to pierce through that channel would certainly be a signal to us to take profits off of the table. In order to keep our interest levels high, PBR will need to maintain support above the 15-dollar mark.

Achillion Pharmaceuticals, Inc. ACHN

Appearing in yesterday’s extended watchlist, ACHN was another play with potential to start off a new week. After a significant morning gap-up, the stock would touch a low of 3.72 before running as high as 4.82, an intraday move of 30%

This morning the company came with a well-timed release concerning its Hep-C drug, and the stock continues to blow its top. The high this morning in premarket trading is 6.47, making ACHN one that we’ll definitely be interested to follow. Per this morning’s PR, there’s a timeline for the testing of this drug leading all the way up to the end of the year, so we’ll stick ACHN on our longer-term radar as well.

NEW HAVEN, Jun 10, 2014 (GLOBE NEWSWIRE via COMTEX) — Initial cohort of HCV-infected patients begin dosing with ACH-3422 for seven days. Clinical trials may continue evaluating 200 mg of sovaprevir for HCV-infected patients. Timelines for reporting proof-of-concept results with ACH-3422, a proprietary uridine-analog nucleotide polymerase inhibitor, during the fall of 2014 and initiating all-oral combination studies by the end of 2014 remain on track >>> FULL PR

TransGlobal Assets, Inc. TMSH

We’ve been following TMSH since last week, and have not been disappointed. The stock has played out a textbook dip-and-rip scenario for the last three sessions straight, offering up many opportunities to make gains.

Yesterday, it came down as low as .0079 before ripping its way up to .0128, a healthy intraday increase of 62% Provided it continues to trade in this manner, we’ll be looking to take advantage of any similar swings to the ones we’ve seen already. We want to see it make higher lows, and break through the channel of resistance between the previous two sessions’ swing highs (.0128-.0139).

Side Note:

Even with so much else to talk about today, we can’t forget about another cash cow in Apple. AAPL Calls have been providing us with some excellent opportunities in recent weeks as well, and we’re still highly attuned to that situation as well.

Extended Watchlist:
DNAX, SPEX, AVNR, SGMS, ATEA, TPLM, KNDI

Blue Horseshoe Stocks: PBR Update & More

Petroleo Brasiliero S.A. (Petrobras) PBR When we touched base with PBR on Wednesday morning, we mentioned that we were expecting some opportunities to come our way provided that the stock could hold support at or above its 200DMA (13.69).

We also showed interest in the July 19th $15 Calls, which, leading up to that point, had been trading in the .30-.38 range, and even ventured so far as to say that a double or triple could be possible. That move came rather quickly over the remainder of the trading week, as those contracts dipped as low as .25, and by the end of the day on Friday had come all the way back to close at .61.

For us, that represented an excellent three-session move, allowing gains of up to 144% for options traders. The stock itself made a modest move up also, to the tune of 8% from 13.62 to 14.77.

The PBR chart is still looking quite ripe, with several bullish indicators catching our attention. The RSI is strengthening rapidly, there appears to be a MACD cross in the making, and provided the stock can maintain support at or above the channel between the 50DMA of 14.19 and Friday’s swing low of 14.32, we like the chances of seeing even more gains from PBR.

For intraday/intraweek flip opportunities, we can look into the $14-$15 Weekly Calls, but granted the overall trend continues, a longer-term play will continue to be the 07/19 $15’s, which as we said, have already afforded us a double-bagger.

Shamika 2 Gold, Inc. SHMX

On Thursday, we added SHMX to the mix as a sub-penny play that had struck us as having some potential. As with the majority of stocks trading in the triple-zero range, SHMX is susceptible to rapid swings in price, and we saw that first hand as we closed out the week. On Friday, the stock saw a low of .0003, and a subsequent upswing to its closing price of .0005.

That made it possible for traders to nab a quick profit of 67% We always want to be extremely cautious when dealing with volatile plays in this price range, as they are not for the faint-hearted. Quick-strike trades are the order of the day, and for more skilled traders, proper timing of each dip and rip can lead to gains really piling up.

Extended Watchlist:
TMSH, TBEV, IDIX, ACHN, SQNM, DRL, PGNX, PFIE, LIVE